Describing Adverse Events Associated with Bilateral Same-Day Intravitreal Dexamethasone Implants

Autor: Russel H. Dinh, Obadah Moushmoush, Peter Kolyvas, Brad A. Jacobsen, Mariam Mathai, Kavya Sanghavi, Joshua D. Levinson, Brian K. Do
Rok vydání: 2022
Předmět:
Zdroj: Ophthalmic Surgery, Lasers and Imaging Retina. 53:612-618
ISSN: 2325-8179
2325-8160
DOI: 10.3928/23258160-20221018-04
Popis: BACKGROUND AND OBJECTIVES: To explore the incidence of adverse events after bilateral same-day intravitreal 0.7-mg dexamethasone implant (SDIDI) injections. MATERIALS AND METHODS: We performed an IRB approved, single-center, retrospective review of patients receiving bilateral SDIDI injections from January 1, 2016 to October 31, 2021 and reviewed adverse events that occurred within 3 months of injection. RESULTS: A total of 206 bilateral (412 eyes) SDIDI injections were performed in 59 patients. Ocular hypertension or the addition of intraocular pressure (IOP) lowering drops occurred in 121 (29.4%) eyes after IDI. Two (0.5%) eyes required glaucoma drainage surgeries. Of the 117 phakic eyes, 32 (27.4%) had progression of cataract or cataract extraction. There were two (0.5%) episodes of vitreous hemorrhage and one (0.2%) retinal tear with retinal detachment. There were no cases of endophthalmitis. CONCLUSION: Serious complication rates after bilateral same-day IDI injections appears low. Increased IOP that requires intervention can occur. [ Ophthalmic Surg Lasers Imaging Retina 2022;53:612–618.]
Databáze: OpenAIRE
Externí odkaz: